- Home
- NVAX vs EDN Comparison
NVAX vs EDN Comparison
Compare NVAX & EDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- EDN
- Stock Information
- Founded
- NVAX 1987
- EDN 1992
- Country
- NVAX United States
- EDN Argentina
- Employees
- NVAX N/A
- EDN N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- EDN Electric Utilities: Central
- Sector
- NVAX Health Care
- EDN Utilities
- Exchange
- NVAX Nasdaq
- EDN Nasdaq
- Market Cap
- NVAX 1.3B
- EDN 1.2B
- IPO Year
- NVAX 1995
- EDN 2007
- Fundamental
- Price
- NVAX $6.84
- EDN $25.30
- Analyst Decision
- NVAX Buy
- EDN
- Analyst Count
- NVAX 5
- EDN 0
- Target Price
- NVAX $16.60
- EDN N/A
- AVG Volume (30 Days)
- NVAX 4.9M
- EDN 89.2K
- Earning Date
- NVAX 08-07-2025
- EDN 08-05-2025
- Dividend Yield
- NVAX N/A
- EDN N/A
- EPS Growth
- NVAX N/A
- EDN N/A
- EPS
- NVAX 2.97
- EDN 0.21
- Revenue
- NVAX $1,254,962,000.00
- EDN $2,097,707,542.00
- Revenue This Year
- NVAX $56.85
- EDN $51.74
- Revenue Next Year
- NVAX N/A
- EDN N/A
- P/E Ratio
- NVAX $2.30
- EDN $6.09
- Revenue Growth
- NVAX 25.92
- EDN 37.57
- 52 Week Low
- NVAX $5.01
- EDN $13.78
- 52 Week High
- NVAX $17.81
- EDN $51.69
- Technical
- Relative Strength Index (RSI)
- NVAX 51.12
- EDN 37.52
- Support Level
- NVAX $6.54
- EDN $24.73
- Resistance Level
- NVAX $7.20
- EDN $28.46
- Average True Range (ATR)
- NVAX 0.28
- EDN 1.42
- MACD
- NVAX 0.06
- EDN 0.03
- Stochastic Oscillator
- NVAX 66.36
- EDN 15.28
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About EDN Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor)
Empresa Distribuidora y Comercializadora Norte SA is engaged in the distribution and sale of electricity. The firm's concession area covers the northern portion of the city of Buenos Aires mainly to residential, commercial, industrial, and public service.